186 related articles for article (PubMed ID: 37183462)
1. Mechanism-based Suppression of Cancer by Targeting DNA-Replicating Enzymes.
Arya P; Malhotra H; Chaudhary B; Sarwara A; Goyal R; Wan C; Mishra DK; Gautam RK
Curr Protein Pept Sci; 2024; 25(1):4-11. PubMed ID: 37183462
[TBL] [Abstract][Full Text] [Related]
2. Harnessing DNA Replication Stress for Novel Cancer Therapy.
Zhu H; Swami U; Preet R; Zhang J
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32854236
[TBL] [Abstract][Full Text] [Related]
3. The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment.
Li S; Wang L; Wang Y; Zhang C; Hong Z; Han Z
J Hematol Oncol; 2022 Oct; 15(1):147. PubMed ID: 36253861
[TBL] [Abstract][Full Text] [Related]
4. Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic.
Cerrato A; Morra F; Celetti A
J Exp Clin Cancer Res; 2016 Nov; 35(1):179. PubMed ID: 27884198
[TBL] [Abstract][Full Text] [Related]
5. Targeting poly(ADP-ribose) glycohydrolase to draw apoptosis codes in cancer.
Tanuma SI; Shibui Y; Oyama T; Uchiumi F; Abe H
Biochem Pharmacol; 2019 Sep; 167():163-172. PubMed ID: 31176615
[TBL] [Abstract][Full Text] [Related]
6. Targeting DNA Replication Stress for Cancer Therapy.
Zhang J; Dai Q; Park D; Deng X
Genes (Basel); 2016 Aug; 7(8):. PubMed ID: 27548226
[TBL] [Abstract][Full Text] [Related]
7. A Review on DNA Repair Inhibition by PARP Inhibitors in Cancer Therapy.
Shah AP; Patel CN; Sureja DK; Sanghavi KP
Folia Med (Plovdiv); 2018 Mar; 60(1):39-47. PubMed ID: 29668451
[TBL] [Abstract][Full Text] [Related]
8. Amplifying tumour-specific replication lesions by DNA repair inhibitors - a new era in targeted cancer therapy.
Helleday T
Eur J Cancer; 2008 May; 44(7):921-7. PubMed ID: 18374562
[TBL] [Abstract][Full Text] [Related]
9. Targeting DNA damage and repair: embracing the pharmacological era for successful cancer therapy.
Aziz K; Nowsheen S; Pantelias G; Iliakis G; Gorgoulis VG; Georgakilas AG
Pharmacol Ther; 2012 Mar; 133(3):334-50. PubMed ID: 22197993
[TBL] [Abstract][Full Text] [Related]
10. Targeting DNA repair and replication stress in the treatment of ovarian cancer.
Murai J
Int J Clin Oncol; 2017 Aug; 22(4):619-628. PubMed ID: 28643177
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in cancer therapy using PARP inhibitors.
Kaur SD; Chellappan DK; Aljabali AA; Tambuwala M; Dua K; Kapoor DN
Med Oncol; 2022 Sep; 39(12):241. PubMed ID: 36180646
[TBL] [Abstract][Full Text] [Related]
12. Targeting DNA repair, DNA metabolism and replication stress as anti-cancer strategies.
Puigvert JC; Sanjiv K; Helleday T
FEBS J; 2016 Jan; 283(2):232-45. PubMed ID: 26507796
[TBL] [Abstract][Full Text] [Related]
13. Poly-ADP-ribose polymerases (PARPs) as a therapeutic target in the treatment of selected cancers.
Przybycinski J; Nalewajska M; Marchelek-Mysliwiec M; Dziedziejko V; Pawlik A
Expert Opin Ther Targets; 2019 Sep; 23(9):773-785. PubMed ID: 31394942
[No Abstract] [Full Text] [Related]
14. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy.
Huang R; Zhou PK
Signal Transduct Target Ther; 2021 Jul; 6(1):254. PubMed ID: 34238917
[TBL] [Abstract][Full Text] [Related]
15. Targeting dePARylation selectively suppresses DNA repair-defective and PARP inhibitor-resistant malignancies.
Chen SH; Yu X
Sci Adv; 2019 Apr; 5(4):eaav4340. PubMed ID: 30989114
[TBL] [Abstract][Full Text] [Related]
16. Targeting DNA damage response and repair genes to enhance anticancer immunotherapy: rationale and clinical implication.
Lamberti G; Andrini E; Sisi M; Federico AD; Ricciuti B
Future Oncol; 2020 Aug; 16(23):1751-1766. PubMed ID: 32539551
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy.
Xu Y; Her C
Biomolecules; 2015 Jul; 5(3):1652-70. PubMed ID: 26287259
[TBL] [Abstract][Full Text] [Related]
18. DNA damage checkpoints: from initiation to recovery or adaptation.
Bartek J; Lukas J
Curr Opin Cell Biol; 2007 Apr; 19(2):238-45. PubMed ID: 17303408
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of Response and Resistance to DNA Repair Targeted Therapies.
Stover EH; Konstantinopoulos PA; Matulonis UA; Swisher EM
Clin Cancer Res; 2016 Dec; 22(23):5651-5660. PubMed ID: 27678458
[TBL] [Abstract][Full Text] [Related]
20. DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment.
Solier S; Zhang YW; Ballestrero A; Pommier Y; Zoppoli G
Curr Cancer Drug Targets; 2012 May; 12(4):356-71. PubMed ID: 22385513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
